ArticleFrontiers in neurology
Development and validation of a prediction model for lower extremity deep vein thrombosis risk in elderly patients with intracerebral hemorrhage.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Geriatric patients are simultaneously exposed to a high risk of both bleeding and thromboembolism, making antithrombotic management for elderly intracerebral hemorrhage patients a dilemma. This study aimed to develop and validate a prediction model for lower extremity deep vein thrombosis risk in elderly patients with intracerebral hemorrhage. Methods: Demographics variables, clinical features and laboratory parameters were retrospectively collected from elderly intracerebral hemorrhage patients at our hospital from August 2023 to July 2024. Multiple imputation was used to handle missing values. Potential predictors of lower extremity deep vein thrombosis (demographic, clinical features and laboratory parameters) were assessed using least absolute shrinkage and selection operator (LASSO) regression for feature selection followed by multivariable logistic regression, a prediction model and a nomogram were constructed. Performance of the model was assessed through the receiver operating characteristic curve (ROC), calibration curve, decision curve analysis (DCA), and clinical impact curve (CIC). Results: Two hundred and forty-seven elderly intracerebral hemorrhage patients were included in the analysis. Five potential predictors were identified after LASSO regression: logDFR, D-dimer, eGFR, GCS and infection. These predictors were subsequently entered into a multivariable logistic regression model. Highly correlated predictors were further assessed to ensure model stability and interpretability. The final model included four independent predictors: logDFR (OR 1.84, 95% CI 1.28-2.63), eGFR (OR 1.01, 95% CI 1.00-1.02), GCS (OR 0.87, 95% CI 0.79-0.96) and infection (OR 2.20, 95% CI 1.05-4.63). The model had an area under the curve (AUC) of 0.819 (95%CI 0.808-0.830), suggesting good discrimination. Internal validation was performed using bootstrap resampling, the estimated optimism was 0.028, representing expected performance. Calibration assessment indicated only moderate overestimation of risk. Decision curve analysis (DCA) and clinical impact curve (CIC) consistently demonstrated the model's applicability across diverse clinical settings. Conclusion: This study developed and validated an effective prediction model, incorporating four clinically accessible parameters, for estimating the risk of lower extremity deep vein thrombosis in elderly patients with intracerebral hemorrhage. This model may facilitate the early identification of high-risk patients, thereby guiding prophylactic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.